About Intrinsic Therapeutics
Intrinsic Therapeutics is a company based in Woburn (United States) founded in 2000. Intrinsic Therapeutics has raised $138.68 million across 8 funding rounds from investors including Credit Suisse, Greenspring Associates and CRG. Intrinsic Therapeutics offers products and services including Barricaid Implant. Intrinsic Therapeutics operates in a competitive market with competitors including Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.
- Headquarter Woburn, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Authentidate Holding Corp
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$138.68 M (USD)
in 8 rounds
-
Latest Funding Round
$28 M (USD), Series D
May 10, 2017
-
Investors
Credit Suisse
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intrinsic Therapeutics
Intrinsic Therapeutics offers a comprehensive portfolio of products and services, including Barricaid Implant.
Implant reduces reherniation risk after discectomy surgery
Funding Insights of Intrinsic Therapeutics
Intrinsic Therapeutics has successfully raised a total of $138.68M across 8 strategic funding rounds. The most recent funding activity was a Series D round of $28 million completed in May 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Intrinsic Therapeutics
Intrinsic Therapeutics has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Credit Suisse, Greenspring Associates and CRG.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
CRG is recognized as a premier healthcare investment partner.
|
Locked | Locked | Locked | |
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Diversified investment management firm
|
Locked | Locked | Locked |
Investor details for Intrinsic Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intrinsic Therapeutics
Investment portfolio details for Intrinsic Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intrinsic Therapeutics
Detailed financials for Intrinsic Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intrinsic Therapeutics Comparisons
Peer comparison for Intrinsic Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intrinsic Therapeutics
Intrinsic Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nevro, ATEC Spine, Vertos Medical, Paradigm Spine and Relievant Medsystems, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of high-frequency spinal cord stimulation implants
|
|
| Locked | Locked | Locked |
Treatment solutions for spine disorders are developed.
|
|
| Locked | Locked | Locked |
Minimally invasive treatments for lumbar spinal stenosis are developed.
|
|
| Locked | Locked | Locked |
Stabilization devices for healthcare are manufactured by the company.
|
|
| Locked | Locked | Locked |
Developer of medical devices for patients suffering from chronic vertebrogenic low back pain
|
|
| Locked | Locked | Locked |
Minimally invasive titanium implants for sacroiliac joint disorders are developed.
|
Detailed competitors of Intrinsic Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intrinsic Therapeutics
Complete news archive for Intrinsic Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intrinsic Therapeutics
Intrinsic Therapeutics was founded in 2000 and raised its 1st funding round 3 years after it was founded.
Intrinsic Therapeutics is headquartered in Woburn, United States. It is registered at Woburn, Massachusetts, United States.
Cary Hagan is the current CEO of Intrinsic Therapeutics.
Intrinsic Therapeutics is a funded company, having raised a total of $138.68M across 8 funding rounds to date.
Intrinsic Therapeutics was founded in 2000 and is based in Woburn, United States. Operations focus on the medical device sector, where implantable prostheses for spinal annulus repair are produced. The Barricaid device is designed for use after limited discectomy to reinforce annular defects and lower reherniation risks. This addresses weaknesses created by nuclear material removal during surgery for disc herniation.
Intrinsic Therapeutics's top competitors include Nevro, Paradigm Spine and ATEC Spine.
Intrinsic Therapeutics offers Barricaid Implant.
Intrinsic Therapeutics has 7 investors. Key investors include Credit Suisse, Greenspring Associates, CRG, NEA, and Quadrille Capital.